| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000038406 |
| Receipt No. | R000043769 |
| Scientific Title | Clinical trial on the efficacy on the wrinkle conforming to the guideline of Japanese Cosmetic Science Society |
| Date of disclosure of the study information | 2019/11/05 |
| Last modified on | 2020/02/04 (Ver. 3) |
| Basic information | ||
| Public title | Clinical trial on the efficacy on the wrinkle conforming to the guideline of Japanese Cosmetic Science Society | |
| Acronym | Clinical trial on the efficacy on the wrinkle conforming to the guideline of Japanese Cosmetic Science Society | |
| Scientific Title | Clinical trial on the efficacy on the wrinkle conforming to the guideline of Japanese Cosmetic Science Society | |
| Scientific Title:Acronym | Clinical trial on the efficacy on the wrinkle conforming to the guideline of Japanese Cosmetic Science Society | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the usefulness of wrinkles of the outer corner of the eyes by long-term continuous use of active ingredient formulated cream. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visual evaluation of wrinkle grade |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | application of cosmetics including active ingredient. | |
| Interventions/Control_2 | application of cosmetics without active ingredient. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Healthy women aged 30 to 59 years old at the time of acquisition.
2) Individuals who are healthy and are currently not treating with any disease. 3) Individuals who have wrinkles of grade 3 to 5 in the outer corner of the eyes. 4) Individuals who obtained the written consent to participate in the study after explanation of the details of the study and understanding it sufficiently |
|||
| Key exclusion criteria | 1) Individuals who have a history of allergy to cosmetics.
2) Individuals undergoing hormone replacement therapy. 3) Individuals who are pregnant or lactating. 4) Individuals who are using cosmetics or quasi-drugs that are effective against wrinkles . 5) Individuals who have experienced cosmetic care that will affect the test site. 6) Individuals who acknowledge that doctors involved in the examination are not appropriate. |
|||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nikoderm Research Inc. | ||||||
| Division name | Evaluation Division | ||||||
| Zip code | 5410052 | ||||||
| Address | 1-6-14, Azuchimachi, Chuoku, Osaka, Japan | ||||||
| TEL | 06-6125-3501 | ||||||
| yyamashita@nikkolgroup.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nikoderm Research Inc. | ||||||
| Division name | Evaluation Division | ||||||
| Zip code | 5410052 | ||||||
| Address | 1-6-14, Azuchimachi, Chuoku, Osaka, Japan | ||||||
| TEL | 06-6125-3501 | ||||||
| Homepage URL | |||||||
| yanno@nikkolgroup.com | |||||||
| Sponsor | |
| Institute | Nikoderm Research Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | COSMOS TECHNICAL CENTER CO.,LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Society for Glycative Stress Resarch |
| Address | 2-13-10,Shinjyuku,Shinjyuku-ku,Tokyo |
| Tel | 03-6709-8842 |
| info@toukastress.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 80 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043769 |